Geisinger, Indivumed Collaborate for Personalized Medicine Initiative | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Geisinger, Indivumed Collaborate for Personalized Medicine Initiative

July 18, 2014
by Rajiv Leventhal
| Reprints

The Danville, Pa.-based Geisinger Health System has announced a new partnership that will afford Geisinger patients access to advanced cancer treatment and clinical trials.

The collaboration with the Hamburg, Germany-based Indivumed, which develops technology for individualized oncology, allows the company to collect samples from consenting patients who are already undergoing a surgical tumor resection.

Upon resection, a portion of the tissue, blood or urine remaining beyond what is required to make a clinical diagnosis will be banked at Geisinger through MyCode, a repository that holds more than 45,000 patient samples. Another portion will be banked by Indivumed, which will analyze the tissue to be used in the development and, eventually, application of targeted therapies for cancer patients.

"Developing targeted pharmaceutical therapies for cancer patients is at the core of our collaboration with Geisinger," Hartmut Juhl, founder and CEO of Indivumed, said in a statement. "Geisinger's advanced electronic health record and clinical data repository coupled with our ability to comprehensively analyze patients' individual cancers provides a unique opportunity to quickly translate new scientific discoveries into the practice of medicine."

Indivumed will integrate its biobanking standard at Geisinger Health System to jointly create a platform that offers opportunities for clinical research focused on tumor biology, officials say.

Indivumed maintains a biobank of tissues and annotated data from more than 20,000 patients—with about 1,500 new cases added per year—each collected under stringent specifications. The overall goal is to understand the biological difference between tumors and how patients respond to treatment to support the implementation of personalized therapy.

Research demonstrates that proteins change expression profiles significantly within minutes following surgical resection. Many of those proteins may serve as biomarkers for new drugs. For this reason, controlled and rapid tissue processing is necessary for understanding biological differences of or within patient tumors, especially when developing targeted therapies.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Geisinger National Precision Health Hires Illumina Exec to Lead Business Development

Integrated health system Geisinger has hired a high-profile genetic counselor to head up business development for Geisinger National Precision Health, which was created to extend the Geisinger model on the national scene.

$30M VC Fund Launched to Spur Innovation in Cardiovascular Care

The American Heart Association, together with Philips and UPMC, has announced the launch of Cardeation Capital, a $30 million collaborative venture capital fund designed to spur healthcare innovation in heart disease and stroke care.

Epic Wins Labor Dispute in Closely Divided Supreme Court Decision

Epic Systems Corporation won a major labor-law ruling in the Supreme Court on Monday, centering around the extent of corporations’ right to force employees to sign arbitration agreements, and with a 5-4 ruling in its favor

Survey: Two-Thirds of Physician Practices Seeking Out Value-Based Care Consulting Firms

Most physician organizations are not prepared for the move to value-based care, and 95 percent CIOs of group practices and large clinics state they do not have the information technology or staff in-house needed to transform value-based care end-to-end, according to a recent Black Book Market Research.

Cumberland Consulting Buys LinkEHR, Provider of Epic Help Desk Services

Cumberland Consulting Group, a healthcare consulting and services firm, has acquired LinkEHR, which provides remote application support, including Epic help desk services.

Population Health Tool that Provides City-Level Data Expands to 500 Cities

A data visualization tool that helps city officials understand the health status of their population, called the City Health Dashboard, has now expanded to 500 of the largest cities in the U.S., enabling local leaders to identify and take action around the most pressing health needs in their cities and communities.